Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma-Reference-Cited by-同舟云学术

Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma

Published:2014-08-10 Issue:3 Volume:94 Page:515-517
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Hasegawa Tetsuo,Aisa Yoshinobu,Shimazaki Kengo,Nakazato Tomonori

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2182-1.pdf

Reference10 articles.

1. Boeckh M, Nichols WG, Papanicolaou G et al (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9:543–558

2. Eid AJ, Razonable RR (2010) New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 70:965–981

3. Torres HA, Kontoyiannis DP, Aguilera EA et al (2006) Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6:393–398

4. Matthew Rong Jie T, Soon Thye L et al (2014) Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma 55(1):182–187

5. Mitsumori T, Sueki Y et al (2014) Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy. Rinsho Ketsueki 55(2):239–243

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections;Expert Review of Hematology;2023-04-03

2. Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study;Journal of Clinical and Experimental Hematopathology;2023

3. Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience;Leukemia & Lymphoma;2022-10-12

4. Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections;Hematology;2022-05-11

5. Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab;Hematology;2022-03-28